Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



In vitro Screening for Protein Tyrosine Phosphatase 1B and Dipeptidyl Peptidase IV Inhibitors from Nigerian Medicinal Plants

Yusuf Saidu, Suleiman Alhaji Muhammad, Abdullahi Abbas Yahaya, Andrew Onu, Ibrahim Tsado Mohammed, Luba Muhammad.




Abstract

Background/Aim: Protein tyrosine phosphatase 1B (PTP1B) and dipeptidyl peptidase IV (DPP IV) have been identified as one of the drug target for the treatment of type 2 diabetes. The current study was designed to screen for PTP1B and DPP IV inhibitors from some Nigerian medicinal plants.
Methods: PTP 1 B and DPP IV Drug Discovery Kits from Enzo Life Sciences were used to investigate in vitro inhibitory effect of crude methanolic extract of 10 plants; Mangifera indica, Moringa oleifera, Acacia nilotica, Arachis hypogea, Senna nigricans, Azadirachta indica, Calotropis procera, Leptadenia hastata, Ziziphus mauritiana and Solanum incanum.
Results: The result indicated PTP IB inhibition by Senna nigricans (68.2±2.29%), Azadirachta indica (67.4±2.80%), Arachis hypogea (57.2±2.50%), Acacia nilotica (55.1±2.19%) and Moringa oleifera (41.2±1.87%) were significantly (P0.05) different from that of sumarin. The DPP IV inhibition by S. incanum (68.1±2.71%) was significantly higher as compared with a known inhibitor, P32/98. S. nigrican (57.0±1.91%), Z. mauritiana (56.6±2.01%), A. hypogea (51.0±1.30%), M. indica (44.6±2.40%), C procera (36.2±2.00%), A. nilotica (35.4±2.10%) and A. indica (33.6±1.50%) show significantly (P

Key words: Type 2 diabetes, PTP IB, DPP IV, inhibition, medicinal plants






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.